These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 26036708)

  • 41. Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.
    Bressler NM; Varma R; Suñer IJ; Dolan CM; Ward J; Ehrlich JS; Colman S; Turpcu A;
    Ophthalmology; 2014 Dec; 121(12):2461-72. PubMed ID: 25148789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic macular edema: changing treatment paradigms.
    Arevalo JF
    Curr Opin Ophthalmol; 2014 Nov; 25(6):502-7. PubMed ID: 25211039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts of pharmacotherapy of diabetic macular edema.
    Haritoglou C; Maier M; Neubauer AS; Augustin AJ
    Expert Opin Pharmacother; 2020 Mar; 21(4):467-475. PubMed ID: 31957495
    [No Abstract]   [Full Text] [Related]  

  • 44. Yearly Treatment Patterns for Patients with Recently Diagnosed Diabetic Macular Edema.
    Moulin TA; Adjei Boakye E; Wirth LS; Chen J; Burroughs TE; Vollman DE
    Ophthalmol Retina; 2019 Apr; 3(4):362-370. PubMed ID: 31014689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.
    Wirkkala J; Kubin AM; Ohtonen P; Yliselä J; Siik T; Hautala N
    BMC Ophthalmol; 2022 Jun; 22(1):258. PubMed ID: 35681133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroids as part of combination treatment: the future for the management of macular edema?
    Bandello F; Battaglia Parodi M; Tremolada G; Lattanzio R; De Benedetto U; Iacono P
    Ophthalmologica; 2010; 224 Suppl 1():41-5. PubMed ID: 20714180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Diabetic Macular Edema.
    Kim EJ; Lin WV; Rodriguez SM; Chen A; Loya A; Weng CY
    Curr Diab Rep; 2019 Jul; 19(9):68. PubMed ID: 31359157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current trends in the pharmacotherapy of diabetic retinopathy.
    Kumar B; Gupta SK; Saxena R; Srivastava S
    J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology.
    Ho AC; Scott IU; Kim SJ; Brown GC; Brown MM; Ip MS; Recchia FM
    Ophthalmology; 2012 Oct; 119(10):2179-88. PubMed ID: 22917890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.
    Matsuda S; Tam T; Singh RP; Kaiser PK; Petkovsek D; Carneiro G; Zanella MT; Ehlers JP
    J Diabetes Complications; 2014; 28(2):166-70. PubMed ID: 24374138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S; Gao J; Xu X
    Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Choice of treatment for diabetic macular edema].
    Yang L; Zhang J
    Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):724-728. PubMed ID: 29050184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology.
    Yeh S; Kim SJ; Ho AC; Schoenberger SD; Bakri SJ; Ehlers JP; Thorne JE
    Ophthalmology; 2015 Apr; 122(4):769-78. PubMed ID: 25576994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
    Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
    Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.
    Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):387-94. PubMed ID: 17803438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Ranibizumab on the Decision to Drive and Vision Function Relevant to Driving in Patients With Diabetic Macular Edema: Report From RESTORE, RIDE, and RISE Trials.
    Bressler NM; Varma R; Mitchell P; Suñer IJ; Dolan C; Ward J; Ferreira A; Ehrlich JS; Turpcu A
    JAMA Ophthalmol; 2016 Feb; 134(2):160-6. PubMed ID: 26584450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.